SU1834289A1 - Method of virus concentration - Google Patents

Method of virus concentration

Info

Publication number
SU1834289A1
SU1834289A1 SU4768093/13A SU4768093A SU1834289A1 SU 1834289 A1 SU1834289 A1 SU 1834289A1 SU 4768093/13 A SU4768093/13 A SU 4768093/13A SU 4768093 A SU4768093 A SU 4768093A SU 1834289 A1 SU1834289 A1 SU 1834289A1
Authority
SU
USSR - Soviet Union
Prior art keywords
virus
virus concentration
concentration
substance
polyethylenepolyamine
Prior art date
Application number
SU4768093/13A
Other languages
Russian (ru)
Inventor
А.И. Дудников
А.А. Гусев
Т.О. Бахуташвили
В.И. Шипилов
В.В. Михалишин
Original Assignee
Всесоюзный научно-исследовательский ящурный институт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Всесоюзный научно-исследовательский ящурный институт filed Critical Всесоюзный научно-исследовательский ящурный институт
Priority to SU4768093/13A priority Critical patent/SU1834289A1/en
Application granted granted Critical
Publication of SU1834289A1 publication Critical patent/SU1834289A1/en

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

FIELD: virology, biotechnology. SUBSTANCE: virus-containing suspension is treated with precipitating substance - polyethylenepolyamine (molecular mass is 16000 Da) which is added at the final concentration 0.05-0.2% followed by deposit separation and its resuspending in required volume. Obtained concentrates retain activity at 4-8 C. Method is used for virus concentration for making agents used for prophylaxis and diagnosis of viral infections. EFFECT: improved method of virus concentration. 5 tbl
SU4768093/13A 1989-12-12 1989-12-12 Method of virus concentration SU1834289A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU4768093/13A SU1834289A1 (en) 1989-12-12 1989-12-12 Method of virus concentration

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU4768093/13A SU1834289A1 (en) 1989-12-12 1989-12-12 Method of virus concentration

Publications (1)

Publication Number Publication Date
SU1834289A1 true SU1834289A1 (en) 1996-04-27

Family

ID=60520253

Family Applications (1)

Application Number Title Priority Date Filing Date
SU4768093/13A SU1834289A1 (en) 1989-12-12 1989-12-12 Method of virus concentration

Country Status (1)

Country Link
SU (1) SU1834289A1 (en)

Similar Documents

Publication Publication Date Title
Thorley-Lawson The transformation of adult but not newborn human lymphocytes by Epstein Barr virus and phytohemagglutinin is inhibited by interferon: the early suppression by T cells of Epstein Barr infection is mediated by interferon.
Rubin et al. On the mechanism of Newcastle disease virus neutralization by immune serum
ATE479742T1 (en) METHOD FOR THE LARGE-SCALE PRODUCTION OF VACCINES
AU2684792A (en) Porcine reproductive respiratory syndrome vaccine and diagnostic
EA199700215A1 (en) PROTECTION AGAINST VIRAL INFECTIONS THROUGH COLONIZATION OF MUSCULAR SHELLS GENETICALLY MODIFIED BACTERIA
ES8503951A1 (en) Immunogenic protein or peptide complex, method of producing said complex and the use thereof as an immune stimulant and as a vaccine.
AU3698697A (en) Method for preserving infectious recombinant viruses, aqueous viral suspension and use as medicament
KR890004725A (en) New way
Šmíd et al. Experimental transmission and electron microscopic demonstration of the virus of haemorrhagic disease of rabbits in Czechoslovakia
ATE130198T1 (en) PREPARATION OF A VIRUS AND PURIFICATION OF VIRUS COATING PROTEINS FOR VACCINE USE.
Scheidler et al. Inactivation of viruses by β-propiolactone in human cyro poor plasma and IgG concentrates
Martin et al. Natural cytotoxicity detected in swine using Aujeszky’s disease virus infected targets
Hahon et al. Interferon production in rat type II pneumocytes and alveolar macrophages
SU1834289A1 (en) Method of virus concentration
Cyr‐Coats et al. Bovine coronavirus‐induced cytopathic expression and plaque formation: Host cell and virus strain determine trypsin dependence
Fantes Interferons: purification and physicochemical aspects
WO2002060924A3 (en) Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding and development of a non-simian recombinant cell line for propagation of the virus and a target for a novel class of antiviral compounds
Graves et al. Early syncytium formation by bovine leukemia virus
DE59813486D1 (en) Process for the preparation of blood plasma products by excluding donations with high parvo B19 virus levels
US3197374A (en) Process for the disaggregation and purification of viruses
Colón et al. Mode of action of an inhibitor from agar on growth and hemagglutination of group A arboviruses
FR2600079B1 (en) VIRAL VECTOR AND RECOMBINANT DNA ENCODING PROTEIN F OF THE VIRUS CAUSAL AGENT OF THE S.I.D.A, CELL CULTURE INFECTED WITH THIS VECTOR, PROCESS FOR PREPARING THE PROTEIN, OBTAINED PROTEIN, VACCINE AND ANTIBODIES OBTAINED
Boxaca et al. The occurrence of virus, interferon, and circulating antibodies in mice after experimental infection with Junin virus
ATE190492T1 (en) USE OF POISON FROM HYMENOPTERA TO PRODUCE A MEDICATION FOR THE TREATMENT OF INFECTIONS CAUSED BY DNA VIRUSES
PT88430A (en) VECTEUR D'EXPRESSION DES PROTEINES DU VIRUSES HIV-2 UN AGENT CAUSAL DU AIDS CULTURE CELLULAIRE INFECTEE OR TRANSFORMEE CE PARTI VECTEUR PROCEDE DE PREPARATION DE PROTEINES ET D'UN VACCIN ET ANTICORPS OBTENUS

Legal Events

Date Code Title Description
REG Reference to a code of a succession state

Ref country code: RU

Ref legal event code: NF4A